» Articles » PMID: 39396143

Efficacy of Bone Morphogenetic Protein in Comparison with Autogenous Bone in Regeneration of Ameloblastoma Bone Defects. A Systematic Review

Overview
Specialty Dentistry
Date 2024 Oct 13
PMID 39396143
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To evaluate the evidence comparing bone morphogenetic proteins (BMPs) and autogenous bone grafts (ABGs) for regenerating bone defects from ameloblastoma.

Material And Methods: An electronic search was performed in PubMed and Scopus from October to December 2023, supplemented by manual searches and review of relevant study reference lists. Cohen's kappa was calculated to assess the interrater reliability between two independent investigators. The methodological quality and risk of bias of the selected articles was assessed using the JBI checklist for case series and the NOS for observational studies.

Results: Nine studies met the inclusion criteria and were selected for the qualitative synthesis. Cohen's kappa (κ) value resulted in 98.21% agreement. A total of 229 participants were included. The BMPs were evaluated in five studies, and four evaluated the ABGs. The BMPs has been tested in 25.76% of the patients, while ABGs were studied in 74.24%. In order to evaluate the final result of regeneration, all the studies based their analysis on postoperative questionnaires, radiographical (CBCT and/or panoramic) and/or clinical examination. The results showed a higher regeneration success rate in the studies where the BMPs was used.

Conclusions: Considering the limitations of the studies and the review, it has been shown that BMPs may yield favorable outcomes in terms of bone regeneration, as compared with ABGs.

Citing Articles

Development of biomaterials for bone tissue engineering based on bile acids.

Liu Y, Liu X, Liu C, Zhang W, Shi T, Liu G J Mater Sci Mater Med. 2025; 36(1):11.

PMID: 39812871 PMC: 11735600. DOI: 10.1007/s10856-024-06850-7.

References
1.
Vered M, Wright J . Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours. Head Neck Pathol. 2022; 16(1):63-75. PMC: 9019005. DOI: 10.1007/s12105-021-01404-7. View

2.
Bibbo C, Nelson J, Ehrlich D, Rougeux B . Bone morphogenetic proteins: indications and uses. Clin Podiatr Med Surg. 2014; 32(1):35-43. DOI: 10.1016/j.cpm.2014.09.005. View

3.
Xu L, Li C, Wang H, Zhu S, Li Y . Distraction Osteogenesis of Fibula Graft for Mandibular Reconstruction Following Ameloblastoma Ablation. J Craniofac Surg. 2018; 30(1):202-204. DOI: 10.1097/SCS.0000000000004970. View

4.
Simon E, Merkx M, Shubi F, Kalyanyama B, Stoelinga P . Reconstruction of the mandible after ablative surgery for the treatment of aggressive, benign odontogenic tumours in Tanzania: a preliminary study. Int J Oral Maxillofac Surg. 2006; 35(5):421-6. DOI: 10.1016/j.ijom.2005.10.009. View

5.
Zekry K, Yamamoto N, Hayashi K, Takeuchi A, Alkhooly A, Abd-Elfattah A . Reconstruction of intercalary bone defect after resection of malignant bone tumor. J Orthop Surg (Hong Kong). 2019; 27(1):2309499019832970. DOI: 10.1177/2309499019832970. View